AGNES NOWAKOWSKI, L.AC
Acupuncture at Juniper Trce, Austin, TX
License number
Texas AC01315
Category
Acupuncture
Type
Acupuncturist
Address
Address
3821 Juniper Trce STE 107, Austin, TX 78738
Phone
(512) 215-9847
Personal information
See more information about AGNES NOWAKOWSKI at radaris.comName
Address
Phone
Austin, TX
Professional information
Agnes Nowakowski, Austin TX
Specialties:
Acupuncturist
Address:
3821 Juniper Trce, Austin, TX 78738
Agnes Nowakowski, Austin TX - LAC
Specialties:
Acupuncture
Address:
3821 Juniper Trce SUITE 107, Austin 78738
(512) 215-9847 (Phone)
(512) 215-9847 (Phone)
Languages:
English
Agnes Nowakowski
Location:
Austin, Texas Area
Industry:
Biotechnology
Ovr110 Antibody Compositions And Methods Of Use
US Patent:
2013023, Sep 5, 2013
Filed:
Apr 24, 2013
Appl. No.:
13/869448
Inventors:
Gundo Diedrich - South San Francisco CA, US
Shu-Hui Liu - Redwood City CA, US
Agnes Nowakowski - Austin TX, US
Shu-Hui Liu - Redwood City CA, US
Agnes Nowakowski - Austin TX, US
Assignee:
diaDexus, Inc. - South San Francisco CA
International Classification:
C07K 16/18, C12N 9/96
US Classification:
800 18, 4241521, 4241781, 435 723, 435 696, 435188, 435332, 435375, 4353201, 5303873, 5303882, 5303913, 5303917, 536 2353
Abstract:
Isolated antibodies and antigen binding fragments thereof directed against Ovr110 which is expressed by head and neck, ovarian, endometrial, kidney, pancreatic, lung or breast cancer are provided. Also provided are cells and methods for their production as well as methods for their use in killing an Ovr110-expressing cancer cells and alleviating or treating an Ovr110-expressing cancer in a mammal. The anti-Ovr110 antibodies modulate Ovr110 function or internalize upon binding to Ovr110 expressed by mammalian cells in vitro and in vivo. Compositions comprising an anti-Ovr110 antibody and a carrier as well as articles of manufacture or kits thereof are also provided. In addition, isolated nucleic acids encoding an anti-Ovr110 antibody, expression vectors containing the isolated nucleic acids, and host cells containing the vectors are provided.
Ovr110 Antibody Compositions And Methods Of Use
US Patent:
2010013, Jun 3, 2010
Filed:
Nov 27, 2007
Appl. No.:
12/516397
Inventors:
Jackie Papkoff - San Francisco CA, US
Gundo Diedrich - South San Francisco CA, US
Shu-Hui Liu - Redwood City CA, US
Agnes Nowakowski - Austin TX, US
Gundo Diedrich - South San Francisco CA, US
Shu-Hui Liu - Redwood City CA, US
Agnes Nowakowski - Austin TX, US
International Classification:
A61K 39/395, C07K 16/00, A61P 35/00, C12N 15/13, C12N 15/63, C12N 5/00, A01K 67/027, G01N 33/53, G01N 33/68
US Classification:
4241361, 5303897, 5303873, 4241741, 5303917, 4241781, 536 2353, 4353201, 435325, 800 18, 435375, 436501, 436 86
Abstract:
Isolated antibodies and antigen binding fragments thereof directed against Ovrl 10 which is expressed by head and neck, ovarian, endometrial, kidney, pancreatic, lung or breast cancer are provided. Also provided are cells and methods for their production as well as methods for their use in killing an Ovrl 10-expressing cancer cells and alleviating or treating an Ovrl 10-expressing cancer in a mammal. The anti-Ovrl 10 antibodies modulate Ovrl 10 function or internalize upon binding to Ovrl 10 expressed by mammalian cells in vitro and in vivo. Compositions comprising an anti-Ovrl 10 antibody and a carrier as well as articles of manufacture or kits thereof are also provided. In addition, isolated nucleic acids encoding an anti-Ovrl 10 antibody, expression vectors containing the isolated nucleic acids, and host cells containing the vectors are provided.